Revised December 2019
The Scientific Director reports to the Director, National Institute on Drug Abuse (NIDA) and is responsible for managing and directing the Institute’s Intramural Research Program (IRP). The Scientific Director is responsible for the scientific trajectory of the IRP and for managing an annual IRP budget of $96 million. The Scientific Director provides leadership to the nation’s public health research program on Substance Use Disorders (SUDs) and addiction by conducting state-of-the-art research on the mechanisms that underlie drug addiction and developing new methods for the treatment of SUDs and dependence.
The IRP conducts basic science research at the molecular, genetic, and cellular levels, using animal models and front-line clinical research to investigate and treat the underpinnings of addiction and SUDs. IRP research is multi-faceted, conceptually integrated, highly innovative, and focused on major problems in the field of addiction. The long-term goal of the research is to better understand the biological and behavioral factors contributing to initiation and maintenance of addiction and dependence (and associated diseases), and to translate this knowledge into clinical strategies and protocols to prevent, treat, and reduce the negative consequences for the individual and for society caused by SUDs and addiction. The IRP produces high impact research in various fields related to SUDs, including medications discovery, clinical care and services, neurobiology, behavioral neuroscience, neuroimaging, and molecular and cellular research.
To implement these goals, the Scientific Director reviews current research programs, recruits high-quality investigators to lead new programs, and develops and creates new scientific initiatives to respond to the most pressing issues related to addiction and SUDs in American society. An important aspect of the program is to provide mentorship and training of pre- and post-doctoral fellows, as well as early-career investigators; and further to assist the career and scientific development of more experienced investigators in basic and clinical sciences related to addiction research. The Scientific Director manages a multi-faceted research program that consists of 400 intramural scientists, administrators, pre/post-doctoral and visiting fellows, and contractors who support and conduct research via eight scientific branches containing 26 independent research programs, four shared core facilities, and a clinical research program.
The Scientific Director serves as a member of NIDA senior leadership and advises the NIDA Director regarding strategic research directions and innovative approaches to support NIDA’s IRP. The Scientific Director also works closely with the NIDA Clinical Director to integrate activities of the intramural program with clinical activities. The Scientific Director identifies opportunities for collaboration with intramural research of other NIH Institutes/Centers, and develops partnerships with industry, academia, and other federal agencies to advance SUD and addiction research.
For more information and application details, go to https://hr.nih.gov/jobs/search/job-1686661 - Due date: March 6, 2020.
Get this Publication
Addiction is a disease that affects both brain and behavior.